← FDA Drug Approvals (Drugs@FDA)

RYZODEG 70/30

BLA · Biologics License Application · Sponsor: NOVO · Approved 2015-09-25

Drug application

FDA Application #

BLA203313

Application type

Biologics License Application

Brand name

RYZODEG 70/30

Generic name

Insulin Aspart

Active ingredients

INSULIN ASPART; INSULIN DEGLUDEC

Dosage form

SOLUTION

Route

SUBCUTANEOUS

Marketing status

Discontinued

Sponsor

NOVO

First approval

2015-09-25

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown